BRInging the Diabetes Prevention Program to GEriatric Populations (NCT05166785)
🩺 Plain-English Summary (8th-Grade Level)
Over 24 million Americans are over 65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction of diabetes after an average follow-up of 3 years. The population of older adults is projected to more than double from 52.5 million in 2019 to \~100 million by 2060, and if projections hold, about half (48.3%) will have prediabetes. The proposed hybrid effectiveness implementation type 1 design will compare a DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm) to an in person DPP tailored for older adults (DPP arm) using a randomized, controlled trial design (n=230). The preliminary data suggests DPP-TOAT is a feasible and acceptable way to deliver the DPP to older adults, and this will be the first study to compare the effectiveness and implementation of two strategies (telehealth versus in-person) to deliver a tailored DPP for the unique needs of the growing population of older adults.
Who can join: Review the eligibility criteria below.
Location: NYU Langone Health — New York, New York
Age range: 65 Years
🧪 Interventions in This Study
- DPP Tailored for Older Adults and delivered via Telehealth (OTHER)
- In-Person Diabetes Prevention Program (DPP) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- NYU Langone Health — New York, New York
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Pre Diabetes
- Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals — Chicago, Illinois
- Glycemic Metrics and Patterns in People With and Without Prediabetes — Bend, Oregon
- Stand up for Your Health With a Sit-stand Desk — Milwaukee, Wisconsin
- Treatment to Regress to Normoglycemia in Women with a Recent History of GDM — Baton Rouge, Louisiana
Explore by condition: All Pre Diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.